Regeneron Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $7.11B | $33.08B | $2.73B |
| FY2024 | $8.41B | $37.76B | $2.49B |
| FY2025 | $9.30B | $40.56B | $3.12B |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $7.11B | $33.08B | $2.73B |
| FY2024 | $8.41B | $37.76B | $2.49B |
| FY2025 | $9.30B | $40.56B | $3.12B |